BRVE insider buying – Braveheart Bio, Inc.
8 insider purchases since 2016 worth $122.6M by 8 different insiders. Last 12 months: 8 purchases, $122.6M. Most recent filing: 2026-08-11.
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Forbion Growth Opportunities Fund III Cooperatief U.A. 10% Owner | $64.8M 1× · 3,600,000 sh | 2026-08-07 2026-08-07 | – | 40,052,048 shares as of 2026-08-07 | Holds - never sold |
| OrbiMed Genesis GP LLC Director | $34.9M 1× · 1,940,000 sh | 2026-08-07 2026-08-07 | – | 273,333 shares as of 2026-08-11 | Holds - never sold |
| Andreessen Marc L 10% Owner | $19.8M 1× · 1,100,000 sh | 2026-08-07 2026-08-07 | – | 9,132,420 shares as of 2026-08-11 | Holds - never sold |
| Murdoch Travis CEO | $1.5M 1× · 83,333 sh | 2026-08-07 2026-08-07 | – | 8,333,637 shares as of 2026-08-07 | Holds - never sold |
| Lubner David Charles Director | $999,990 1× · 55,555 sh | 2026-08-07 2026-08-07 | – | 55,555 shares as of 2026-08-07 | Holds - never sold |
| Rickey James Paul CFO | $499,986 1× · 27,777 sh | 2026-08-07 2026-08-07 | – | 703,575 shares as of 2026-08-07 | Holds - never sold |
| Malek David I Director | $74,988 1× · 4,166 sh | 2026-08-07 2026-08-07 | – | 1,013,297 shares as of 2026-08-07 | Holds - never sold |
| Anderson Michele A. Officer | $19,998 1× · 1,111 sh | 2026-08-07 2026-08-07 | – | 332,161 shares as of 2026-08-07 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2026 | 8 | $122.6M | 8 | – | – |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-11 | OrbiMed Genesis GP LLC | Director | 1,940,000 | $18.00 | $34.9M | +19.5% | SEC |
| 2026-08-11 | Andreessen Marc L | 10% Owner | 1,100,000 | $18.00 | $19.8M | +12.0% | SEC |
| 2026-08-07 | Rickey James Paul | CFO | 27,777 | $18.00 | $499,986 | +5.6% | SEC |
| 2026-08-07 | Murdoch Travis | CEO | 83,333 | $18.00 | $1.5M | +2.9% | SEC |
| 2026-08-07 | Malek David I | Director | 4,166 | $18.00 | $74,988 | +0.8% | SEC |
| 2026-08-07 | Lubner David Charles | Director | 55,555 | $18.00 | $999,990 | SEC | |
| 2026-08-07 | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% Owner | 3,600,000 | $18.00 | $64.8M | +44.8% | SEC |
| 2026-08-07 | Anderson Michele A. | Officer | 1,111 | $18.00 | $19,998 | +0.3% | SEC |
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free